Clinical Trial Examines Whether Ambroxol Can Slow Dementia in People with Parkinson's
9 Articles
9 Articles
Common cough medicine could slow dementia progression, scientists say
A year-long clinical trial has found that Ambroxol, a cough syrup commonly sold across Europe, could potentially slow the progression of dementia in Parkinson's disease patients.The study, published in JAMA Neurology, monitored 55 participants with Parkinson's dementia and discovered that psychiatric symptoms remained stable in those taking the medication, while the placebo group experienced worsening symptoms.The research offers hope for the ne…
Cough medicine could help protect against form of dementia, study finds
A COMMON cough medicine could help protect against dementia. A study found that it prevented people with Parkinson’s develop the memory-destroying disease. GettyA cough medicine prescribed for decades in Europe – called ambroxol – could stabilise the progression of Parkinson’s dementia[/caption] Around 145,000 people in the UK have Parkinson’s, a progressive brain disease that affects movement – but they’re also more likely to develop certain fo…
Cough medicine Ambroxal shows potential to slow Parkinson's-related dementia
Dementia poses a major health challenge with no safe, affordable treatments to slow its progression. Researchers at Lawson Research Institute (Lawson), the research arm of St. Joseph's Health Care London, are investigating whether Ambroxol—a cough medicine used safely for decades in Europe—can slow dementia in people with Parkinson's disease.


This common medicine could slow dementia, scientists say
Cough medicine widely used in Europe remains unapproved for use in US, Canada, researchers say
Coverage Details
Bias Distribution
- 43% of the sources lean Right
To view factuality data please Upgrade to Premium